View More Recent Stories

Jun 6, 2022 08:30AM Avinger Announces Presentations by Key Opinion Leaders at New Cardiovascular Horizons Annual Conference
May 16, 2022 08:00AM Avinger Announces Key Opinion Leader Presentation and Live Case at Vascular Conferences in Germany
May 10, 2022 04:02PM Avinger Reports First Quarter 2022 Results
Apr 29, 2022 09:00AM Avinger to Announce First Quarter 2022 Results on May 10
Mar 22, 2022 04:03PM Avinger (AVGR) Reports Q4 Revenue of $2.4M, Net Loss of $5M
Mar 22, 2022 04:01PM Avinger Reports Fourth Quarter and Year End 2021 Results
Mar 15, 2022 07:30AM Avinger to Announce Full-Year 2021 Results on March 22
Mar 14, 2022 08:03AM Avinger (AVGR) to Effect 1-for-20 Reverse Stock Split
Mar 14, 2022 08:00AM Avinger to Effect One-for-Twenty Reverse Stock Split
Mar 7, 2022 07:30AM Avinger Expands Lightbox 3 First Case Experience
Feb 28, 2022 08:15AM Avinger Announces Successful Completion of First Cases with the Lightbox 3 Next Generation Imaging Console
Jan 11, 2022 08:32AM Avinger (AVGR) Granted 510(k) Clearance for Lightbox 3 Next-Generation Imaging Console
Jan 11, 2022 08:30AM Avinger Announces 510(k) Clearance for Lightbox 3 Next-Generation Imaging Console
Nov 17, 2021 08:31AM Avinger (AVGR) Announces FDA Clearance of Pantheris for the Treatment of In-Stent Restenosis
Nov 17, 2021 08:30AM Avinger Announces FDA Clearance of Pantheris for the Treatment of In-Stent Restenosis
Nov 11, 2021 04:01PM Avinger Reports Third Quarter 2021 Financial Results
Oct 29, 2021 08:30AM Avinger to Announce Third Quarter Results on November 11, 2021
Sep 8, 2021 08:45AM Avinger To Present at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15
Aug 16, 2021 08:00AM Avinger OCT-Guided Technologies Featured at AMP 2021
Aug 10, 2021 04:01PM Avinger Reports Second Quarter 2021 Financial Results
Aug 9, 2021 07:32AM Avinger (AVGR) Announces 510(k) Filing for New Lightbox 3 Imaging Console
Aug 9, 2021 07:30AM Avinger Announces 510(k) Filing for New Lightbox 3 Imaging Console
Jul 27, 2021 04:00PM Avinger to Announce Second Quarter 2021 Results on August 10, 2021
Jul 6, 2021 08:30AM Avinger Announces 510(k) Filing for New Pantheris In-Stent Restenosis Indication
Jun 28, 2021 08:45AM Avinger Announces Key Opinion Leader Presentations at Vascular Conferences in Germany
Jun 7, 2021 08:00AM Avinger Announces Presentations by Key Opinion Leaders at New Cardiovascular Horizons Annual Conference
May 17, 2021 08:00AM Avinger To Present at the Oppenheimer MedTech, Tools & Diagnostics Summit May 26
May 6, 2021 04:01PM Avinger Reports First Quarter 2021 Financial Results
Apr 26, 2021 08:30AM Avinger to Announce First Quarter 2021 Results on May 6, 2021
Apr 21, 2021 08:00AM New Publications Highlight Clinical Benefits of Avinger PAD Therapies
Apr 15, 2021 08:00AM Avinger Achieves Commercial Milestone with More Than 100 Accounts Using Pantheris SV
Apr 8, 2021 08:30AM Avinger Provides Update on Tigereye(TM) Commercial Launch
Mar 11, 2021 04:01PM Avinger Reports Fourth Quarter 2020 Financial Results
Mar 11, 2021 04:01PM Avinger Reports Fourth Quarter 2020 Financial Results
Mar 11, 2021 08:35AM Avinger, Inc. to Present at the Q1 Virtual Investor Summit
Mar 2, 2021 08:00AM Avinger to Announce Fourth Quarter Full Year 2020 Results on March 11, 2021
Sep 7, 2016 04:11PM Avinger (AVGR) and HealthTrust Sign Agreement on Lumivascular Technology
Sep 7, 2016 04:01PM Avinger Signs Agreement with HealthTrust for Lumivascular Technology
Jul 27, 2015 02:13PM Trading Radar for 7/28: Ford (F), Twitter (TWTR) DuPont (DD), Pfizer (PFE), UPS (UPS), US Steel (X) Report
View More Recent Stories